Laparoscopic Bariatric Surgery and Erector Spinae Plane Block
Obesity, Postoperative Pain, Bariatric Surgery
About this trial
This is an interventional prevention trial for Obesity focused on measuring Erector spinae plane (ESP) block, Laparoscopic bariatric surgery, Obesity, Postoperative pain
Eligibility Criteria
Inclusion Criteria:
- elective bariatric surgery
- American Society of Anesthesiology (ASA) II-III
- 18 - 65 years
- body mass index (BMI) 40-60 kg/m2
Exclusion Criteria:
- ASA ≥4
- under 18 years of age or over 65 years of age
- declining to give written informed consent
- have neurological and/or psychiatric disorders
- cooperation cannot be established
- accompanying laparoscopic cholecystectomy or paraumbilical hernia repair
- history of bariatric surgery
- the block cannot be applied due to bleeding disorders or localized skin infection at the injection site
- with hepatic, neuromuscular, cardiac and/or renal failure
- history of allergy to the local anesthetics
- patients undergoing open surgery
Sites / Locations
- Antalya Training and Research Hospital, Department of Anesthesiology and Reanimation
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
ESP block group
Control group
Before anaesthesia induction; bilateral ESP block will be performed under the guidance of USG. Patients will be administered paracetamol 1 gr IV every 8 hours in the postoperative period. Standardized postoperative tramadol i.v. patient controlled analgesia (PCA) protocol will be performed (3 mg/ml, total volume 100 ml, 10 mg bolus dose, 20 min locked period, without continuous delivery, no basal infusion).
Patients will be administered paracetamol 1 gr IV every 8 hours in the postoperative period. Standardized postoperative tramadol i.v. PCA analgesia protocol will be performed (3 mg/ml, total volume 100 ml, 10 mg bolus dose, 20 min locked period, without continuous delivery, no basal infusion).